Orthofix receives ‘hold’ rating — 5 facts

Zacks analysts downgraded Orthofix shares from a “buy” rating to a “hold” rating, according to MidSouth News & Analysis.

Advertisement

Here are five facts:

 

1. On Wednesday, Orthofix shares traded up 1.13 percent.

 

2. The company has a one-year low of $27.85.

 

3. The one-year high is $42.61.

 

4. Orthofix has a market cap of $743.85 million.

 

5. The 50-day moving average is $35.98 and 200-day moving average is $35.01.

 

More articles on orthopedics:
3 notes on AAOS’ new Hip, Knee & Adult Reconstruction Evaluation Committee member
Drs. Charles Rush, Sean Dingle provide charity care in Cuba: 4 notes
American Osteopathic Academy of Orthopedics names Dr. George Zimmerman president — 5 highlights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.